Evotec SE (EVO) is a pharmaceutical preparations company incorporated in Germany, listed on the Nasdaq. With a market capitalization of $1.2 billion, Evotec SE is a small-cap company. The stock currently trades at $3.28, down 3.53% today, with a 52-week range of $2.84–$4.80.
No 10-K filings found.